Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Site search
Search
Menu
Search
Subscribe
Home
Contact Us
Subscription Services
Promote Your Event
e-Edition
News
Sports
Entertainment
Obituaries
Photos
Videos
e-Edition
Classifieds
Place an Ad
Best of 2022
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Abvc Biopharma Inc
(NQ:
ABVC
)
1.260
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 30, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
931
Open
1.260
Bid (Size)
1.240 (16)
Ask (Size)
1.340 (15)
Prev. Close
1.260
Today's Range
1.260 - 1.260
52wk Range
0.6739 - 18.70
Shares Outstanding
24,420,526
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why American Eagle Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
November 21, 2023
Shares of American Eagle Outfitters, Inc. (NYSE: AEO) declined during Tuesday’s session after the company reported third-quarter financial results. Net revenue rose 5% Y/Y to $1.30 billion, beating the...
Via
Benzinga
US Stocks Down; Chicago Fed National Activity Index Falls In October
November 21, 2023
U.S. stocks traded lower this morning, with the Dow Jones index falling more than 80 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.25% to 35,062.20 while the NASDAQ...
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Performance
YTD
-79.00%
-79.00%
1 Month
+16.67%
+16.67%
3 Month
-3.82%
-3.82%
6 Month
-81.23%
-81.23%
1 Year
-82.94%
-82.94%
More News
Read More
ABVC BioPharma Receives U.S. Patent for ADHD Treatment, a $32 Billion Market
November 21, 2023
Via
NewMediaWire
Topics
Intellectual Property
Exposures
Intellectual Property
ABVC BioPharma Enters Definitive Agreement with Licensing Income Worth $467M and Royalties Up to $200M
November 16, 2023
Via
NewMediaWire
ABVC BioPharma Reports Third Quarter 2023 Financial and Operational Results
November 15, 2023
Via
NewMediaWire
12 Health Care Stocks Moving In Monday's Intraday Session
October 30, 2023
Via
Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
October 27, 2023
Via
Benzinga
What's Going On With ABVC Biopharma Stock Friday?
October 27, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 27, 2023
Via
Benzinga
Crude Oil Down 2.5%; Mastercard Posts Upbeat Earnings
October 26, 2023
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
12 Health Care Stocks Moving In Thursday's Intraday Session
October 26, 2023
Via
Benzinga
Why Harley-Davidson Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
October 26, 2023
Via
Benzinga
Dow Dips Over 100 Points; US GDP Growth Tops Expectations
October 26, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
US Stocks Mixed; Bristol Myers Posts Upbeat Earnings
October 26, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
What In The World Is Going On With ABVC BioPharma Stock?
October 26, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 26, 2023
Via
Benzinga
ABVC BioPharma Entered Into a Term Sheet to License Global Rights of CNS Drugs with the Indications of MDD and ADHD to AiBtl BioPharma at the Valuation of $667 Million
October 26, 2023
Via
NewMediaWire
12 Health Care Stocks Moving In Monday's Intraday Session
October 23, 2023
Via
Benzinga
ABVC BioPharma Announces Completion of Subject Recruitment for Interim Analysis on ADHD Phase IIb Clinical Study
October 17, 2023
Via
NewMediaWire
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 09, 2023
Via
Benzinga
ABVC BioPharma Receives Taiwanese Patent for Its Treatment of Major Depressive Disorder (MDD)
October 09, 2023
Via
NewMediaWire
Topics
Intellectual Property
Exposures
Intellectual Property
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
September 19, 2023
Via
Benzinga
5 Value Stocks To Watch In The Healthcare Sector
August 28, 2023
Via
Benzinga
ABVC BioPharma Provides Updates on ADHD Phase IIb Clinical Study
August 23, 2023
Via
NewMediaWire
ABVC Executes Cooperation Agreement for Strategic Investments
August 17, 2023
Via
NewMediaWire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.